Semi-Annual Report — FY2026 H1
What CREATE MEDIC CO.,LTD. reported for the period from 2026-01-01 to 2026-12-31.
Filed 2026-08-10View the original on EDINET
How much it says
57Typical
What moved here
10named for the first time
Its own wording
19terms
Which filing this is
35/ 35newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
During the interim consolidated accounting period, revenue increased year on year, while operating income, ordinary income and interim net income attributable to owners of the parent all declined due to a higher cost-of-sales ratio and increased expenses associated with developing new overseas markets. The Group also saw changes in its financial position and cash flows as a result of supplier diversification and stronger bargaining power, expansion of sales channels into India and Southeast Asia, and the acquisition of treasury shares.
Komori's summary of this document, not the document's own words.57Typical
How much this filing saysA weighted roll-up of 10 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 33 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
73
Detailed
45
Typical
88
Very detailed
75
Very detailed
41
Thin
55
Typical
100
Very detailed
0
Almost nothing
0
Almost nothing
73
Detailed
R&D spend4億円Money spent making new things.
Cash left over4億円Cash from the business, less what went into equipment.
Spent on equipment3億円Plants, machines — things meant to last.
EmployeesNot disclosedThis document does not carry the figure.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.